Please try another search
Walgreens Boots Alliance (NASDAQ:WBA) reported its Q3 2023 financial results on Thursday, revealing a 9.2% year-over-year (YoY) increase in revenue to $35.42 billion, surpassing estimates from Zacks Consensus Estimate. However, the company's earnings per share (EPS) fell to $0.67 from $0.80 YoY, missing the EPS estimates.
The company also reported a higher number of locations than anticipated, ending with 8,720 locations compared to the estimated 8,689. Additionally, Walgreens saw a significant increase in comparable sales for U.S. Retail Pharmacy - Pharmacy at 9.2%, significantly higher than the estimated 0.6%.
Revenues across various segments showed varied performance against estimates and YoY changes. The U.S. Retail Pharmacy segment generated $21.13 billion, while revenues from the U.S. Retail Pharmacy- Retail and International - Wholesale segments amounted to $6.54 billion and $2.90 billion respectively.
Despite these results, Walgreens is currently ranked #4 (Sell) by Zacks, indicating potential underperformance in the near term. This ranking comes even as its shares returned +3.2% over the past month, outperforming the Zacks S&P 500 composite's -2.4% change.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.